TLR tolerance as a treatment for central nervous system autoimmunity

Journal of Immunology

Volumn 197, Issue 6, 2016, Pages 2110-2118

  Anstadt, Emily J ^a   Fujiwara, Mai ^a   Wasko, Nicholas ^a   Nichols, Frank ^a   Clark, Robert B ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR 2; UNCLASSIFIED DRUG; LIPOPEPTIDE; S-(2,3-BIS(PALMITOYLOXY)PROPYL)CYSTEINE; TLR2 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 2;

ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; FLOW CYTOMETRY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MICROBIOME; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TH17 CELL; ANIMAL; C57BL MOUSE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; IMMUNOLOGY; PHYSIOLOGY; SPLEEN;

ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; LIPOPEPTIDES; MICE; MICE, INBRED C57BL; SPLEEN; TH17 CELLS; TOLL-LIKE RECEPTOR 2;

EID: 84988917206     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1600876     Document Type: Article

References (34)

1. Farrokhi, V., R. Nemati, F. C. Nichols, X. Yao, E. Anstadt, M. Fujiwara, J. Grady, D.Wakefield,W. Castro, J. Donaldson, and R. B. Clark. 2013. Bacterial lipodipeptide, Lipid 654, is a microbiome-associated biomarker for multiple sclerosis. Clin. Transl. Immunology 2: e8.
2. Hasheminia, S. J., S. H. Zarkesh-Esfahani, S. Tolouei, V. Shaygannejad, H. Shirzad, and M. Hashemzadeh Chaleshtory. 2014. Toll like receptor 2 and 4 expression in peripheral blood mononuclear cells of multiple sclerosis patients. Iran. J. Immunol. 11: 74-83.
3. Sloane, J. A., C. Batt, Y. Ma, Z. M. Harris, B. Trapp, and T. Vartanian. 2010. Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2. Proc. Natl. Acad. Sci. USA 107: 11555-11560.
4. Correale, J., and M. F. Farez. 2013. Parasite infections in multiple sclerosis modulate immune responses through a retinoic acid-dependent pathway. J. Immunol. 191: 3827-3837.
5. Nyirenda, M. H., E. Morandi, U. Vinkemeier, D. Constantin-Teodosiu, S. Drinkwater, M. Mee, L. King, G. Podda, G. X. Zhang, A. Ghaemmaghami, et al. 2015. TLR2 stimulation regulates the balance between regulatory T cell and Th17 function: a novel mechanism of reduced regulatory T cell function in multiple sclerosis. J. Immunol. 194: 5761-5774.
6. Prinz, M., F. Garbe, H. Schmidt, A. Mildner, I. Gutcher, K. Wolter, M. Piesche, R. Schroers, E. Weiss, C. J. Kirschning, et al. 2006. Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J. Clin. Invest. 116: 456-464.
7. Herrmann, I., M. Kellert, H. Schmidt, A. Mildner, U. K. Hanisch, W. Brück, M. Prinz, and R. Nau. 2006. Streptococcus pneumoniae infection aggravates experimental autoimmune encephalomyelitis via Toll-like receptor 2. Infect. Immun. 74: 4841-4848.
8. Miranda-Hernandez, S., N. Gerlach, J. M. Fletcher, E. Biros, M. Mack, H. Korner, and A. G. Baxter. 2011. Role for MyD88, TLR2 and TLR9 but not TLR1, TLR4 or TLR6 in experimental autoimmune encephalomyelitis. J. Immunol. 187: 791-804.
9. Reynolds, J. M., B. P. Pappu, J. Peng, G. J. Martinez, Y. Zhang, Y. Chung, L. Ma, X. O. Yang, R. I. Nurieva, Q. Tian, and C. Dong. 2010. Toll-like receptor 2 signaling in CD4(+) T lymphocytes promotes T helper 17 responses and regulates the pathogenesis of autoimmune disease. Immunity 32: 692-702.
10. Shaw, P. J., M. J. Barr, J. R. Lukens, M. A. McGargill, H. Chi, T. W. Mak, and T. D. Kanneganti. 2011. Signaling via the RIP2 adaptor protein in central nervous system-infiltrating dendritic cells promotes inflammation and autoimmunity. Immunity 34: 75-84.
11. Li, H., P. Gonnella, F. Safavi, G. Vessal, B. Nourbakhsh, F. Zhou, G. X. Zhang, and A. Rostami. 2013. Low dose zymosan ameliorates both chronic and relapsing experimental autoimmune encephalomyelitis. J. Neuroimmunol. 254: 28-38.
12. Manicassamy, S., R. Ravindran, J. Deng, H. Oluoch, T. L. Denning, S. P. Kasturi, K. M. Rosenthal, B. D. Evavold, and B. Pulendran. 2009. Toll-like receptor 2-dependent induction of vitamin A-metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits autoimmunity. Nat. Med. 15: 401-409.
13. Manoharan, I., Y. Hong, A. Suryawanshi, M. L. Angus-Hill, Z. Sun, A. L. Mellor, D. H. Munn, and S. Manicassamy. 2014. TLR2-dependent activation of beta-catenin pathway in dendritic cells induces regulatory responses and attenuates autoimmune inflammation. J. Immunol. 193: 4203-4213.
14. Wang, Y., K. M. Telesford, J. Ochoa-Repáraz, S. Haque-Begum, M. Christy, E. J. Kasper, L. Wang, Y. Wu, S. C. Robson, D. L. Kasper, and L. H. Kasper. 2014. An intestinal commensal symbiosis factor controls neuroinflammation via TLR2-mediated CD39 signalling. Nat. Commun. 5: 4432.
15. Biswas, S. K., and E. Lopez-Collazo. 2009. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol. 30: 475-487.
16. Clark, R. B., J. L. Cervantes, M. W. Maciejewski, V. Farrokhi, R. Nemati, X. Yao, E. Anstadt, M. Fujiwara, K. T. Wright, C. Riddle, et al. 2013. Serine lipids of Porphyromonas gingivalis are human and mouse Toll-like receptor 2 ligands. Infect. Immun. 81: 3479-3489.
17. Brocke, S., C. Piercy, L. Steinman, I. L. Weissman, and T. Veromaa. 1999. Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment. Proc. Natl. Acad. Sci. USA 96: 6896-6901.
18. Adams, C. O., W. J. Housley, S. Bhowmick, R. E. Cone, T. V. Rajan, F. Forouhar, and R. B. Clark. 2010. Cbl-b(2/2) T cells demonstrate in vivo resistance to regulatory T cells but a context-dependent resistance to TGF-beta. J. Immunol. 185: 2051-2058.
19. Korn, T., J. Reddy,W. Gao, E. Bettelli, A. Awasthi, T. R. Petersen, B. T. Bäckström, R. A. Sobel, K. W. Wucherpfennig, T. B. Strom, et al. 2007. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 13: 423-431.
20. Barbarese, E., H. Soares, S. Yang, and R. B. Clark. 1992. Comparison of CNS homing pattern among murine TH cell lines responsive to myelin basic protein. J. Neuroimmunol. 39: 151-162.
21. Lehner, M. D., S. Morath, K. S. Michelsen, R. R. Schumann, and T. Hartung. 2001. Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different Toll-like receptors independent of paracrine mediators. J. Immunol. 166: 5161-5167.
22. Sato, S., F. Nomura, T. Kawai, O. Takeuchi, P. F. Muhlradt, K. Takeda, and S. Akira. 2000. Synergy and cross-tolerance between Toll-like receptor (TLR) 2-and TLR4-mediated signaling pathways. J. Immunol. 165: 7096-7101.
23. Hayashi, T., C. S. Gray, M. Chan, R. I. Tawatao, L. Ronacher, M. A. McGargill, S. K. Datta, D. A. Carson, and M. Corr. 2009. Prevention of autoimmune disease by induction of tolerance to Toll-like receptor 7. Proc. Natl. Acad. Sci. USA 106: 2764-2769.
24. Park, J. H., S. Y. Jeong, A. J. Choi, and S. J. Kim. 2015. Lipopolysaccharide directly stimulates Th17 differentiation in vitro modulating phosphorylation of RelB and NF-kB1. Immunol. Lett. 165: 10-19.
25. Reynolds, J. M., G. J. Martinez, Y. Chung, and C. Dong. 2012. Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation. Proc. Natl. Acad. Sci. USA 109: 13064-13069.
26. Diterich, I., C. Rauter, C. J. Kirschning, and T. Hartung. 2003. Borrelia burgdorferiinduced tolerance as a model of persistence via immunosuppression. Infect. Immun. 71: 3979-3987.
27. Cole, T. S., M. Zhang, T. J. Standiford, M. Newstead, J. Luther, J. Zhang, C. C. Chen, and J. Y. Kao. 2012. IRAK-M modulates expression of IL-10 and cell surface markers CD80 and MHC II after bacterial re-stimulation of tolerized dendritic cells. Immunol. Lett. 144: 49-59.
28. Kim, D. H., J. C. Lee, S. Kim, S. H. Oh, M. K. Lee, K. W. Kim, and M. S. Lee. 2011. Inhibition of autoimmune diabetes by TLR2 tolerance. J. Immunol. 187: 5211-5220.
29. Kokubu, Y., K. Tabu, N. Muramatsu, W. Wang, Y. Murota, I. Nobuhisa, M. Jinushi, and T. Taga. 2016. Induction of protumoral CD11c(high) macrophages by glioma cancer stem cells through GM-CSF. Genes Cells 21: 241-251.
30. McNelis, J. C., and J. M. Olefsky. 2014. Macrophages, immunity, and metabolic disease. Immunity 41: 36-48.
31. Nguyen, M. T., S. Favelyukis, A. K. Nguyen, D. Reichart, P. A. Scott, A. Jenn, R. Liu-Bryan, C. K. Glass, J. G. Neels, and J. M. Olefsky. 2007. A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. J. Biol. Chem. 282: 35279-35292.
32. Huber, S., N. Gagliani, E. Esplugues, W. O'Connor, Jr., F. J. Huber, A. Chaudhry, M. Kamanaka, Y. Kobayashi, C. J. Booth, A. Y. Rudensky, et al. 2011. Th17 cells express interleukin-10 receptor and are controlled by Foxp3-and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner. Immunity 34: 554-565.
33. Hedl, M., J. Li, J. H. Cho, and C. Abraham. 2007. Chronic stimulation of Nod2 mediates tolerance to bacterial products. Proc. Natl. Acad. Sci. USA 104: 19440-19445.
34. Schuijs, M. J., M. A. Willart, K. Vergote, D. Gras, K. Deswarte, M. J. Ege, F. B. Madeira, R. Beyaert, G. van Loo, F. Bracher, et al. 2015. Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells. Science 349: 1106-1110.